ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1108

More Frequent, Earlier Hip Involvement and Poor Outcome in Spondyloarthritis Associated with Familial Mediterranean Fever

Murat Bektaş1, Selma Sari2, Cigdem Cetin3, Banu Cicek Yalcin Dulundu2, Nevzat Koca2, Burak Ince2, Yasemin Yalcinkaya3, Bahar Esen3, Murat İnanç4, Lale Öcal4 and Ahmet Gül5, 1Istanbul Faculty of Medicine, Istanbul, Turkey, 2Istanbul Faculty of Medicine, Istanbul University, Division of Rheumatology, İstanbul, Turkey, 3Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, 4Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey, 5Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey

Meeting: ACR Convergence 2021

Keywords: Familial Mediterrenean Fever, hip involvement, MEFV, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Clinical Features & Diagnostics (1083–1117)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Familial Mediterranean Fever (FMF), an autoinflammatory disease, is characterized by self-limited inflammatory attacks. A significant proportion of patients with FMF experience episodes of acute monoarthritis, however 5 % of patients have chronic arthritis, usually of hips or knees. In this study we aimed to evaluate clinical and laboratory characteristics, genotype/phenotype correlation, outcome and biological DMARD responses in patients with FMF-associated SpA (FMF/SpA) who followed up in our tertiary referral clinic.

Methods: One hundred and twenty-four patients with FMF who fulfilled Tel Hashomer criteria and coexisting SpA were evaluated. After exclusion of 13 patients with missing data, 111 patients included into the analysis. Diagnosis of SpA was made by ASAS and/or modified New York criteria (mNYC). Axial radiographic changes were evaluated and scored according to Bath Ankylosing Spondylitis Radiology Index (BASRI) in plain radiography.

Results: One hundred and eleven patients whom 53.2% were female included into the analysis. Mean follow-up time and patient age were 93.6±76.9 (3-324) months, 43.5±12.3 (20-87) years, respectively. Clinical and laboratory characteristics of study participants were summarized in table 1. SpA subtypes were; axial in 23.4%, axial and peripheral in 62.6% and only peripheral in 14% in FMF/SpA group. 56.1% (80.7% bilaterally) of patients had hip involvement, 34.7% knee and 27.7% ankle arthritis. Overall, 23.3% underwent total joint replacement (TJR) in patients with FMF/SpA. Hip involvement and need for TJR were higher in FMF/SpA group compared to control group (table 1).

While 79 results were available, most frequent MEFV variant was M694V homozygote (44.3%). Hip involvement was higher in patients who had two MEFV variants compared to one copy and M694V homozygous compared to others. Need for TJR was higher in M694V homozygous compared to other MEFV variants. Radiographic sacroiliitis was lower in patients with FMF/SpA compared to control group but similar both in patients who had two MEFV variants compared to one copy and M694V homozygous compared to other MEFV variants. HLA-B27 positivity was lower in patients with FMF/SpA compared to control group (table 2)

Average BASRI hip scores were higher in patients with FMF/SpA compared to SpA only (p=0.01) and also higher both had two MEFV variants compared to one copy (p=0.01) and M694V homozygous compared to other MEFV variants (p< 0.001). Average BASRI-spine scores were higher in patients with SpA compared to FMF/SpA group (p=0.02); but did not differ among various MEFV variants. Average BASRI-total scores did not differ in patients with FMF/SpA and control group and only higher in patients had M694V homozygous compared to other MEFV variants (p=0.035) (table 2).

Conclusion: In our study, hip involvement and need for TJR were associated with MEFV carriage rather than HLA-B27 positivity and higher in patients with FMF/SpA compared to the patients with SpA alone. Our study indicates that the patients with FMF/SpA had more severe disease course including worse outcome and destructive hip involvement than those with SpA alone, especially in patients carrying two copy MEFV variants and M694V homozygous.

SD: standard deviation, CRP: C reactive protein, ESR: Erythrocyte sedimentation rate, OR: Odds ratio, TJR: Total joint replacement, mNYC: modifyed New York criteria, b-DMARD: Biological disease modifying antirheumatic drugs Ɨ during the attack free period *Mann Whitney U test

SD: standard deviation, IQR: Interquartile range, CRP: C reactive protein, ESR: Erythrocyte sedimentation rate, OR: Odds ratio, TJR: Total joint replacement, mNYC: modifyed New York criteria, b-DMARD: Biological disease modifying antirheumatic drugs Ɨ during the attack free period *Mann Whitney U test

*Mann Whitney U test Ɨ According to modified New York Criteria SD: standard deviation, FMF: Familial Mediterranean Fever, SpA: Spondyloarthritis, IQR: Interquartile range, CRP: C reactive protein, OR: Odds ratio, TJR: Total joint replacement, ESRD: End stage renal disease


Disclosures: M. Bektaş, None; S. Sari, None; C. Cetin, None; B. Dulundu, None; N. Koca, None; B. Ince, None; Y. Yalcinkaya, None; B. Esen, None; M. İnanç, None; L. Öcal, None; A. Gül, None.

To cite this abstract in AMA style:

Bektaş M, Sari S, Cetin C, Dulundu B, Koca N, Ince B, Yalcinkaya Y, Esen B, İnanç M, Öcal L, Gül A. More Frequent, Earlier Hip Involvement and Poor Outcome in Spondyloarthritis Associated with Familial Mediterranean Fever [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/more-frequent-earlier-hip-involvement-and-poor-outcome-in-spondyloarthritis-associated-with-familial-mediterranean-fever/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/more-frequent-earlier-hip-involvement-and-poor-outcome-in-spondyloarthritis-associated-with-familial-mediterranean-fever/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology